Sunburst Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.13M Buy
976
+2
+0.2% +$2.36K 0.18% 52
2026
Q2
$1.17M Buy
974
+8
+0.8% +$8.17K 0.19% 52
2026
Q1
$888K Buy
966
+19
+2% +$19.3K 0.16% 57
2025
Q4
$1.02M Buy
947
+22
+2% +$21K 0.21% 47
2025
Q3
$706K Sell
925
-1
-0.1% -$744 0.15% 58
2025
Q2
$722K Buy
926
+51
+6% +$39.6K 0.16% 53
2025
Q1
$723K Hold
875
– – 0.18% 55
2024
Q4
$675K Buy
875
+10
+1% +$8.28K 0.17% 61
2024
Q3
$766K Sell
865
-6
-0.7% -$5.39K 0.19% 56
2024
Q2
$788K Hold
871
– – 0.21% 54
2024
Q1
$662K Buy
871
+8
+0.9% +$5.69K 0.19% 60
2023
Q4
$503K Buy
863
+29
+3% +$16.9K 0.16% 65
2023
Q3
$448K Buy
834
+8
+1% +$4.12K 0.16% 61
2023
Q2
$387K Buy
826
+5
+0.6% +$2.1K 0.14% 70
2023
Q1
$282K Sell
821
-1
-0.1% -$337 0.1% 80
2022
Q4
$301K Buy
822
+68
+9% +$24.1K 0.12% 77
2022
Q3
$244K Hold
754
– – 0.12% 77
2022
Q2
$244K Hold
754
– – 0.12% 76
2022
Q1
$216K Sell
754
-1
-0.1% -$257 0.11% 69
2021
Q4
$209K Buy
+755
New +$191K 0.11% 70

Other funds holding LLY

Sunburst Financial Group's LLY Position: Q3 2026 in Review

Sunburst Financial Group increased its Eli Lilly (LLY) stake by 0.21% in Q3 2026, buying an estimated $2.36K and bringing the position to 976 shares worth $1.13M. The position accounts for 0.18% of the portfolio, ranked #52.

Sunburst Financial Group first reported a position in LLY in Q4 2021 and has held it in 20 quarters since. The position peaked at $1.17M in Q2 2026. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Sunburst Financial Group held 976 shares of Eli Lilly worth $1.13M as of Q3 2026.
  • Sunburst Financial Group bought 2 Eli Lilly shares in Q3 2026, an estimated $2.36K.
  • Eli Lilly made up 0.18% of Sunburst Financial Group's portfolio in Q3 2026, its #52 holding.
  • Sunburst Financial Group first reported a position in Eli Lilly in Q4 2021 and has held it in 20 quarters since.
  • Sunburst Financial Group's Eli Lilly position peaked at $1.17M in Q2 2026.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Sunburst Financial Group's 13F filing for Q3 2026, filed 9 Oct 2026.